Login
Login
E-mail
Password

Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Iscriviti gratuitamente
Registrazione
  1. Home
  2. Azioni
  3. Israele
  4. TEL AVIV STOCK EXCHANGE
  5. Bonus BioGroup Ltd.
  6. Notizie
  7. Altre lingue
    BONS   IL0004850116

BONUS BIOGROUP LTD.

(BONS)
Prezzo di chiusura TEL AVIV STOCK EXCHANGE  -  14/08/2022
0.3290 ILS   +6.47%
31/05Bonus BioGroup Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2022
CI
28/04Il farmaco COVID di Bonus BioGroup - MesenCure - può aiutare una complicazione pericolosa per la vita vista nei pazienti di cancro
CI
31/03Bonus BioGroup Ltd. Riferisce i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2021
CI
RiassuntoQuotazioniGraficiNotizieSocietąFinanza 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su BONUS BIOGROUP LTD.
05/08BONUS BIOGROUP LTD.(TASE: BONS) dropped from TA-125 Index
31/05Bonus BioGroup Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
28/04Bonus BioGroup's COVID Drug - MesenCure - Can Help a Life-threatening Complication Seen..
11/04BONUS BIOGROUP: Company Presentation
31/03Bonus BioGroup Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
2021Bonus BioGroup Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ende..
2021BONUS BIOGROUP LTD.(TASE: BONS) added to S&P Global BMI Index
2021Bonus Biogroup Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
2021BONUS BIOGROUP LTD.(TASE: BONS) added to TA-125 Index
2021Bonus Biogroup Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
2021Bonus BioGroup Ltd. announced that it expects to receive ILS 13.0105 million in funding..
2020Bonus BioGroup Reports Preliminary Pre-Clinical Results in an Animal Model for Its Nove..
2020Wize Pharma Inc.'s Strategic Transaction Partner Bonus BioGroup Initiates Preclinical S..
2020Bonus BioGroup Ltd. Auditor Raises 'Going Concern' Doubt
2020Bonus BioGroup Ltd. announced that it expects to receive ILS 25.641 million in funding ..
2019Bonus BioGroup Ltd. announced that it expects to receive ILS 3.03273 million in funding
2019Bonus BioGroup Ltd. Auditor Raises 'Going Concern' Doubt
2018Bonus BioGroup Ltd. announced that it has received ILS 17.860566 million in funding
2018Bonus BioGroup Ltd. Auditor Raises 'Going Concern' Doubt
2018Bonus BioGroup Ltd. announced that it has received ILS 9 million in funding
2016Bonus BioGroup Ltd. Auditor Raises 'Going Concern' Doubt
2015Bonus BioGroup Ltd. announced that it has received ILS 1.2 million in funding
2015Bonus BioGroup Ltd. announced that it expects to receive ILS 1.2 million in funding
2015Bonus BioGroup Ltd. Auditor Raises 'Going Concern' Doubt
2014Onus BioGroup Announces Successful Performance of Transplantation of Proprietary Live B..
2014Bonus BioGroup Ltd. Auditor Raises 'Going Concern' Doubt
2013Bonus BioGroup Ltd. Auditor Raises 'Going Concern' Doubt
2013Bonus BioGroup Ltd. Begins Construction of Plant to Produce Regenerated Bone
2012Bonus BioGroup Ltd. announced that it has received ILS 3.94 million in funding.
2012Bonus BioGroup Ltd. announced that it expects to receive ILS 3.94 million in funding.
2012BoneUs Therapeutics Ltd. completed the acquisition of Oceana Advanced Industries Ltd. i..
Prossimi eventi del settore
16/08/22NIBEC CO., LTD.: Primo semestre 2022 Pubblicazione dei risultati (proiezione)
15/09/22CHEMOMETEC A/S: Esercizio 2022 Pubblicazione dei risultati
23/09/22COLLPLANT BIOTECHNOLOGIES LTD.: Primo semestre 2022 Pubblicazione dei risultati (proiezione)
27/10/22MIMEDX GROUP, INC.: Q3 2022 Pubblicazione dei risultati (proiezione)
Settore
Sanitą
Biotecnologia/Farmaceutici
 Biotecnologia e ricerca medica
  Biotecnologia
   Dispositivi medici biologici